Caredx Inc (CDNA) ticks all the boxes for top investors with its surprise performance of -11.37% last month.

A new trading day began on Tuesday, with Caredx Inc (NASDAQ: CDNA) stock price down -15.84% from the previous day of trading, before settling in for the closing price of $31.31. CDNA’s price has ranged from $4.80 to $34.84 over the past 52 weeks.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Sponsored

A company in the Healthcare sector has jumped its sales by 33.42% annually for the last half of the decade. Meanwhile, its annual earnings per share averaged 76.37%. With a float of $49.35 million, this company’s outstanding shares have now reached $51.50 million.

In an organization with 643 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 64.34%, operating margin of -25.59%, and the pretax margin is -53.73%.

Caredx Inc (CDNA) Insider and Institutional Ownership

As we move forward, let’s examine how large-scale investors are investing in this stock of the Diagnostics & Research Industry. The insider ownership of Caredx Inc is 6.43%, while institutional ownership is 96.87%. The most recent insider transaction that took place on Aug 20 ’24, was worth 1,309,087. In this transaction an insider of this company sold 39,466 shares at a rate of $33.17, taking the stock ownership to the 284,983 shares. Before that another transaction happened on Aug 21 ’24, when Company’s See Remarks sold 21,557 for $32.58, making the entire transaction worth $702,327. This insider now owns 284,983 shares in total.

Caredx Inc (CDNA) Latest Financial update

According to the Wall Street analysts, stocks earnings will be around 76.37% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 20.00% during the next five years compared to -21.96% drop over the previous five years of trading.

Caredx Inc (NASDAQ: CDNA) Trading Performance Indicators

Here are Caredx Inc’s current performance indicators. According to the last quarter’s results, the stock had a quick ratio of 3.85. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 4.68.

For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.99, a number that is poised to hit -0.26 in the next quarter and is forecasted to reach -0.76 in one year’s time.

Technical Analysis of Caredx Inc (CDNA)

Let’s dig in a bit further. During the last 5-days, its volume was 1.21 million. That was better than the volume of 0.9 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 47.29%. Additionally, its Average True Range was 2.33.

During the past 100 days, Caredx Inc’s (CDNA) raw stochastic average was set at 61.30%, which indicates a significant increase from 20.43% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 103.74% in the past 14 days, which was higher than the 81.37% volatility it showed in the past 100 days.

At the time of writing, stock’s 50-day Moving Average is $29.58, while its 200-day Moving Average is $16.55. However, in the short run, Caredx Inc’s stock first resistance to watch stands at $28.92. Second resistance stands at $31.48. The third major resistance level sits at $33.62. If the price goes on to break the first support level at $24.22, it is likely to go to the next support level at $22.08. The third support level lies at $19.52 if the price breaches the second support level.

Caredx Inc (NASDAQ: CDNA) Key Stats

With a market capitalization of 1.39 billion, the company has a total of 52,084K Shares Outstanding. Currently, annual sales are 280,320 K while annual income is -190,280 K. The company’s previous quarter sales were 92,270 K while its latest quarter income was -1,390 K.